David-Alexandre C. Gros
2017 - Alnylam Pharmaceuticals
In 2017, David-Alexandre C. Gros earned a total compensation of $16.9K as Former Senior Vice President, Chief Business Officer former principal financial officer at Alnylam Pharmaceuticals, a 99% decrease compared to previous year.
Compensation breakdown
| Salary | $8,313 |
|---|---|
| Other | $8,541 |
| Total | $16,854 |
Gros received $8.5K in other compensation, accounting for 51% of the total pay in 2017.
Gros also received $8.3K in salary.
Rankings
In 2017, David-Alexandre C. Gros' compensation ranked 14,610th out of 14,666 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 14,610 out of 14,666 | 0th |
Division Manufacturing | 5,750 out of 5,772 | 0th |
Major group Chemicals And Allied Products | 2,070 out of 2,075 | 0th |
Industry group Drugs | 1,726 out of 1,731 | 0th |
Industry Pharmaceutical Preparations | 1,330 out of 1,333 | 0th |
Source: SEC filing on March 23, 2018.
Gros' colleagues
We found six more compensation records of executives who worked with David-Alexandre C. Gros at Alnylam Pharmaceuticals in 2017.
2017
Manmeet Soni
Alnylam Pharmaceuticals
Chief Financial Officer
2017
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2017
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2017
Barry Greene
Alnylam Pharmaceuticals
President
2017
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2017
Michael Mason
Alnylam Pharmaceuticals